| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 The Lloyd Rigler Sleep Apnea Research Laboratory, Unit of Anatomy and Cell Biology, and 2 The Laboratory for Shock and Trauma Research, The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
CORRESPONDENCE: L. Lavie, Unit of Anatomy and Cell Biology, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, POB 9649, 31096, Haifa, Israel. Fax: 972 48295403/972 48343934. E-mail: lenal@techunix.technion.ac.il
Keywords: Atherosclerosis, CD8+ T-lymphocytes, cytotoxicity, nasal continuous positive airway pressure treatment, obstructive sleep apnoea, perforin
Received: September 2, 2004
Accepted January 10, 2005
T-lymphocytes are implicated in the development of atherosclerosis. The aim of this study was to assess whether the CD8+ T-lymphocytes of obstructive sleep apnoea (OSA) patients undergo phenotypic and functional changes that may exaggerate atherogenic sequelae in OSA.
A total of 36 OSA patients, 17 controls and 15 single-night-treated OSA patients were studied. Phenotype and cytotoxicity against K562 target cells were analysed by flow cytometry. Cytotoxicity against human umbilical vein endothelial cells (HUVECs) was assessed by 51Cr release assay.
The cytotoxicity of the CD8+ T-lymphocytes of OSA patients against K562 and HUVECs was significantly greater than controls. This increased cytotoxicity directly depended on the presence of perforin and natural killer receptors (CD56, CD16), which were significantly increased in OSA CD8+ T-lymphocytes. Also the percentage of the CD56bright subset, which mediates initial interactions with vascular endothelium, significantly increased in OSA. Nasal continuous positive airway pressure treatment significantly decreased CD8+ T-cell cytotoxicity and CD56 expression, and was positively correlated with natural killer inhibitory NKB1 receptor expression either after a single-night treatment or after a prolonged treatment.
In conclusion, the CD8+ T-lymphocytes of obstructive sleep apnoea patients undergo phenotypic and functional changes, rendering them cytotoxic to target cells via increased CD56+/perforin+ expression, which can be ameliorated by nasal continuous positive airway pressure treatment. These results are compatible with the current authors' hypothesis of atherogenic sequelae in obstructive sleep apnoea.
This article has been cited by other articles:
|
|
 |
|
  L. Dyugovskaya, A. Polyakov, P. Lavie, and L. Lavie Delayed Neutrophil Apoptosis in Patients with Sleep Apnea Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 544 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gozal and L. Kheirandish-Gozal Cardiovascular Morbidity in Obstructive Sleep Apnea: Oxidative Stress, Inflammation, and Much More Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 369 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Buyse, J. Hedner, and the participants of working group 2 Sleep apnoea, hypertension and vascular disease: where are we now? Eur. Respir. Rev., December 1, 2007; 16(106): 169 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Punjabi, B. A. Beamer, A. Jain, M. E. Spencer, and N. Fedarko Elevated Levels of Neopterin in Sleep-Disordered Breathing Chest, October 1, 2007; 132(4): 1124 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tzouvelekis, I. Kotsianidis, P. Steiropoulos, and D. Bouros Role of CD146 in Detection of Apoptotic Circulating Endothelial Cells in Obstructive Sleep Apnea Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1346a - 1347. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Johansson, P. Eriksson, Y. Peker, J. Hedner, L. Rastam, and U. Lindblad The influence of patent foramen ovale on oxygen desaturation in obstructive sleep apnoea Eur. Respir. J., January 1, 2007; 29(1): 149 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schulz The vascular micromilieu in obstructive sleep apnoea Eur. Respir. J., May 1, 2005; 25(5): 780 - 782. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
